FundaMental Pharma Revenue

Biotechnology Research • Nikola-Tesla-Str. 1, Heidelberg, Germany • 11-20 Employees

FundaMental Pharma revenue & valuation

Annual revenue	$1,500,000
Revenue per employee	$137,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,800,000
Total funding	$13,300,000

Key Contacts at FundaMental Pharma

Dirk Beher

Chief Executive Officer

Michael Albers

Director Preclinical Development

Jing Yan

Senior Director Of Research

Hilmar Bading

Founder

Company overview

Headquarters	Nikola-Tesla-Str. 1, Heidelberg, Baden-Württemberg 69124, DE
Website	fundamentalpharma.com
NAICS	541714
Founded	2016
Employees	11-20
Socials

FundaMental Pharma Email Formats

FundaMental Pharma uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@fundamentalpharma.com), used 54.5% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@fundamentalpharma.com	54.5%
{first name}.{last name}	john.doe@fundamentalpharma.com	45.5%

About FundaMental Pharma

FundaMental Pharma is engaged in pioneering research on a novel type of dual-acting modulators of the N-methyl-D-aspartate receptor (NMDAR) for treatment-resistant depression (TRD): • NMDAR/TRPM4 complex disruption modulates extrasynaptic NMDAR signaling, thereby boosting antidepressant efficacy and providing neuroprotection • NMDAR antagonism represents a clinically validated antidepressive mechanism of action with rapid onset and substantial efficacy in TRD patients Our clinical candidate FMP374 is a dual-acting molecule with a higher affinity for the NMDA receptor than the current standard of care esketamine and is orally bioavailable. Most remarkably, efficacy in preclinical depression models occurs at low nanomolar unbound brain drug concentrations and remains separated by 10-20-fold from the exaggerated pharmacology that limits esketamine and other NMDA antagonists.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

Entry

C-Suite

Employees by Department

FundaMental Pharma has 4 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore FundaMental Pharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-12-17	3	$10,400,000
2024-05-11	3	$2,900,000

Funding Insights

$13,300,000

Total funding amount

$2,900,000

Most recent funding amount

Number of funding rounds

FundaMental Pharma Tech Stack

Discover the technologies and tools that power FundaMental Pharma's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

Emotion

Development

Squarespace Commerce

Ecommerce

reCAPTCHA

Security

Apple iCloud Mail

Webmail

Lightbox

JavaScript libraries

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Frequently asked questions

FundaMental Pharma is located in Nikola-Tesla-Str. 1, Heidelberg, DE.

FundaMental Pharma generates an estimated annual revenue of $1,500,000. This revenue figure reflects the company's market position and business performance in its industry.

FundaMental Pharma has an estimated valuation of $4,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

FundaMental Pharma was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

FundaMental Pharma has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

FundaMental Pharma has raised a total of $13,300,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at FundaMental Pharma

Dirk Beher

Chief Executive Officer

Michael Albers

Director Preclinical Development

Jing Yan

Senior Director Of Research

Hilmar Bading

Founder

4.8

40,000 users